Netherlands: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
From Profit Distribution Ban To A New Cap-and-conditions Regime In Dutch Healthcare
The Dutch government has announced a significant shift in healthcare regulation, moving away from a fragmented prohibition on profit distribution toward a uniform 'cap-and-conditions' regime that will apply to all healthcare and youth aid providers. This new approach permits profit distribution up to a maximum percentage of invested capital, but only under strict conditions including quality standards, financial health requirements, and enhanced governance measures. The proposed changes also introduce tight
Netherlands Healthcare
LL
Loyens & Loeff
See more
See more
Article
Dutch FDI Regime Scope Expanded: Six New Technology Categories Will Qualify As Highly Sensitive From 1 January 2027
The Dutch government has announced a significant expansion of its foreign direct investment screening regime, adding six new technology categories to the list of "sensitive technologies" subject to mandatory notification requirements. These additions reflect growing concerns about technological competition and national security risks associated with emerging technologies that could be weaponized or create strategic dependencies.
Netherlands Technology
LL
Loyens & Loeff
See more
Article
From Profit Distribution Ban To A New Cap-and-conditions Regime In Dutch Healthcare
The Dutch government has announced a significant shift in healthcare regulation, moving away from a fragmented prohibition on profit distribution toward a uniform 'cap-and-conditions' regime that will apply to all healthcare and youth aid providers. This new approach permits profit distribution up to a maximum percentage of invested capital, but only under strict conditions including quality standards, financial health requirements, and enhanced governance measures. The proposed changes also introduce tight
Netherlands Healthcare
LL
Loyens & Loeff
See more